Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      UNKNOWN
      Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD
      Description

      This study is designed to evaluate the safety, tolerability and clinical activity of RXI-109 administered by intravitreal injection to reduce the progression of subretinal fibrosis in subjects with advanced neovascular age-related macular degeneration (NVAMD).

      Conditions
      Age-related Macular DegenerationSubfoveal Choroidal NeovascularizationSubretinal ScarringSubretinal Fibrosis
      Talk to us
      TERMINATED
      Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD
      Description

      The objective is to evaluate the safety of intravitreal Fovista® (anti-PDGF BB) administered in combination with anti-VEGF therapy.

      Conditions
      Age-related Macular Degeneration
      Talk to us